RxDoctor Payments Data

Ashley Schwass, PA

Physician Assistant · Berkeley, CANPI 1891190724

Payments from drug & device makers

$1,826in general payments, 2019–2025

Across 73 payments — averaging $25.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$266
  • Astellas Pharma US Inc$134
  • Merck$130
  • Johnson & Johnson$116
  • Novartis$110
  • Seagen Inc.$104
  • plus $966 from 26 others

What the payments were for

  • Food & beverage$1,56185%
  • Education$26515%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,826 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$57,993
Medicare patients
415
Services billed
774

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TagrissoOsimertinib Mesylate14$208,853
XareltoRivaroxaban15$14,932
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$724
Anastrozole42$627
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$309
Levothyroxine Sodium16$283
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine18$266
Oxycodone Hcl18$260
Ondansetron Hcl17$227
Potassium Chloride26$201
Prochlorperazine Maleate11$189
Prednisone48$183
Gabapentin18$173
Ondansetron OdtOndansetron14$146
Omeprazole13$80

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaTagrisso$266$208,85314 claims
Johnson & JohnsonXarelto$116$14,93215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Berkeley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →